Subramanian Yegneswaran

Title: Subramanian Yegneswaran: Innovating Monoclonal Antibody Treatments

Introduction

Subramanian Yegneswaran is an accomplished inventor based in Pleasanton, California. With a keen focus on medical research, Yegneswaran has made significant contributions to the field of biochemistry, specifically through his innovative work on monoclonal antibodies.

Latest Patents

Yegneswaran holds a patent for "Epitope of optimized humanized monoclonal antibodies against activated protein C and uses thereof." This patent presents optimized humanized antibodies that selectively bind to and inhibit activated protein C while avoiding interaction with unactivated protein C. Notably, the antibodies are designed to bind to specific epitopes located outside the catalytic triad of the active site of human activated protein C. The methods of treatment employing these antibodies have the potential to advance therapeutic options in medical science.

Career Highlights

Yegneswaran currently works with the Oklahoma Medical Research Foundation, where he contributes to cutting-edge research and development in the biomedical sector. His role involves extensive research and experimentation aimed at improving patient outcomes through innovation in antibody therapies.

Collaborations

Throughout his career, Yegneswaran has collaborated with talented colleagues such as Xiao-Yan Zhao and Andreas Wilmen. These collaborations highlight the collective effort in the research community to push the boundaries of knowledge and develop effective treatments.

Conclusion

Subramanian Yegneswaran's contributions to the field of monoclonal antibodies exemplify the power of innovation in addressing complex medical challenges. His patent serves as a testament to his dedication and expertise, paving the way for future advancements in therapy using optimized antibodies. Yegneswaran stands as a noteworthy figure in the world of inventors, making impactful strides in medical research.